ATOSIBAN EVER PHARMA 37.5 mg/5 ml, concentrate for solution for infusion bottle, 5 ml
Active ingredients: Atosiban acetate, Atosiban
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusionbottle, 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATOSIBAN EVER PHARMA 37,5 mg/5 mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- EVER VALINJECT (AUTRICHE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Sept 2017
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67905662CIP75502665CIP133400955026655Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATOSIBANsolution | 37,5 mg · 5 ml de solution | FT |
| ACÉTATE D'ATOSIBANsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.